Silence Open To A Partner But Ready To Go It Alone On Lp(a) Drug

Rivals Novartis and Amgen are already in Phase III with Lp(a) drugs

 
• By Jessica Merrill
  
race
Silence is further behind Novartis and Amgen to develop a drug to treat Lp(a). • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Cardiovascular

More from Therapy Areas